Users Discontinuing Slimming Jabs Regain Weight Far More Rapidly Compared to Dieters

Fresh analysis indicates that individuals who stop using popular slimming jabs like semaglutide or tirzepatide tend to recover lost weight far faster than those who end traditional diet and exercise programs.

Research printed in a major medical journal demonstrates that while overweight individuals can lose about a fifth of their body weight while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such treatments should be cognizant of the danger of fast rebound weight gain when the medication ends," cautioned expert Dr. Susan Jebb.

This pace of recovery means a reversion to pre-treatment mass within about a year and a half.

Comparing Approaches

The study, which examined 37 of trials involving over 9,000 of participants, contrasted the results of the injectable medications with conventional dieting.

Researchers emphasize that individuals who lose weight through lifestyle changes alone typically have a more gradual weight regain—perhaps 100 grams monthly—once they finish.

Understanding the Quick Regain

Nutrition scientists believe the way of the injections is key to understanding the accelerated rebound.

These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Long-term administration of the hormone levels several times higher than the body's typical production could lead to the system to produce less of its own natural GLP-1, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.

"Stopping of this hormone supplement leads to appetite is no longer kept in check, making excessive eating much more probable."

An Ongoing Disease?

The NHS suggest the jabs for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

A number of clinicians say that, due to the significant potential of relapse, the therapy is often life-long.

This view is reinforced by drug manufacturers, who state that the results "underscore the persistent character of obesity," similar to managing diseases like hypertension.

User Experiences

Users who have come off the jabs report a sudden resurgence of cravings.

"I experienced a trigger that goes on and you become ravenous," said one woman.

This difficulty is exacerbated if users have not established sustainable lifestyle or habit changes during therapy.

Widespread Adoption

Survey data suggest that a significant number of adults in the UK have tried these injections in the past year, with demand remaining high.

• Adoption is higher among females compared to males.
• The middle-aged demographic shows the greatest usage rates.
• A large proportion obtain the drugs through private healthcare rather than the NHS.

Ultimately, researchers stress that while these medications are potent tools for shedding pounds, they are not a magic cure and lasting health benefits hinges on ongoing behavioural support.